Potentially Effective Treatment for Hepatocellular Carcinoma

Article

Liver cancer cells died when the AURKA-MYC interaction was inhibited.

Researchers in a recent study found a new molecular mechanism that can inhibit the growth of hepatocellular carcinoma in humans and mice.

It was discovered that in liver cancers such as hepatocellular carcinoma where the protein p53 is disturbed or inhibited, the interaction between Aurora kinase A (AURKA) and MYC proteins are crucial. Inhibiting the AURKA protein with drug molecules stops this interaction and causes cancer cells to die, according to the study published in Nature Medicine.

Researchers analyzed the interaction between the AURKA and MYC proteins through computer-aided molecular modeling, which also revealed which drugs inhibited the interactions and which did not.

Through targeting the AURKA protein, it could potentially prevent the growth of p53-altered liver cancer and be used to develop new treatments for this cancer, the study concluded.

Related Videos
Team of care workers with women at the center -- Image credit: Delmaine Donson/peopleimages.com | stock.adobe.com
Image Credit: SciePro - stock.adobe.com
Pharmacist selling medications in the pharmacy | Image Credit: rh2010 - stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.